- Home
- ITOS vs ESOA Comparison
ITOS vs ESOA Comparison
Compare ITOS & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- ESOA
- Stock Information
- Founded
- ITOS 2011
- ESOA 2006
- Country
- ITOS United States
- ESOA United States
- Employees
- ITOS N/A
- ESOA N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- ESOA Water Sewer Pipeline Comm & Power Line Construction
- Sector
- ITOS Health Care
- ESOA Industrials
- Exchange
- ITOS Nasdaq
- ESOA Nasdaq
- Market Cap
- ITOS 271.1M
- ESOA 261.4M
- IPO Year
- ITOS 2020
- ESOA 2006
- Fundamental
- Price
- ITOS $7.41
- ESOA $13.72
- Analyst Decision
- ITOS Strong Buy
- ESOA
- Analyst Count
- ITOS 3
- ESOA 0
- Target Price
- ITOS $21.33
- ESOA N/A
- AVG Volume (30 Days)
- ITOS 512.7K
- ESOA 331.9K
- Earning Date
- ITOS 11-12-2024
- ESOA 12-16-2024
- Dividend Yield
- ITOS N/A
- ESOA 0.22%
- EPS Growth
- ITOS N/A
- ESOA 243.18
- EPS
- ITOS N/A
- ESOA 1.51
- Revenue
- ITOS $35,000,000.00
- ESOA $351,876,861.00
- Revenue This Year
- ITOS $271.18
- ESOA $1.35
- Revenue Next Year
- ITOS N/A
- ESOA N/A
- P/E Ratio
- ITOS N/A
- ESOA $9.09
- Revenue Growth
- ITOS N/A
- ESOA 15.71
- 52 Week Low
- ITOS $7.09
- ESOA $5.22
- 52 Week High
- ITOS $18.75
- ESOA $19.83
- Technical
- Relative Strength Index (RSI)
- ITOS 36.39
- ESOA 43.19
- Support Level
- ITOS $7.09
- ESOA $15.24
- Resistance Level
- ITOS $7.53
- ESOA $19.83
- Average True Range (ATR)
- ITOS 0.37
- ESOA 1.62
- MACD
- ITOS -0.02
- ESOA -0.41
- Stochastic Oscillator
- ITOS 21.28
- ESOA 3.47
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.